相似文献
1
[Treatment of hepatitis C infection. A revolution should not hide another].
Presse Med. 2014 Apr;43(4 Pt 1):339-40. doi: 10.1016/j.lpm.2013.12.009. Epub 2014 Mar 21.
2
[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
MMW Fortschr Med. 2011 Jul 21;153(29-31):17.
3
[Therapy of hepatitis C: new inhibitors as hammers against HCV].
MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:10-1.
4
[Hepatitis C update: what has changed? What can we expect in the near future?].
MMW Fortschr Med. 2013 Nov 7;155(19):59-62. doi: 10.1007/s15006-013-2335-5.
5
[New triple therapy in chronic hepatitis C. Increased patient chances].
MMW Fortschr Med. 2011 Sep 29;153(39):20.
6
[New times for the treatment of chronic hepatitis C].
Ugeskr Laeger. 2012 Mar 19;174(12):795.
7
Impact of HCV protease-inhibitor-based triple therapy for chronic HCV genotype 1 infection.
Antivir Ther. 2011;16(8):1187-201. doi: 10.3851/IMP1934.
8
Infectious diseases. First specific drugs raise hopes for hepatitis C.
Science. 2011 Apr 8;332(6026):159-60. doi: 10.1126/science.332.6026.159.
9
[Chronic hepatitis C: improved cure rates with new approved medications].
MMW Fortschr Med. 2012 Jun 21;O 154 Suppl 2:65-9; quiz 70. doi: 10.1007/s15006-012-0771-2.
10
[Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
MMW Fortschr Med. 2014 Jun 12;156 Suppl 1:53.
Zotero 插件